Evidence map›Paper›PMID 32423553›Full record

ReviewVascular pharmacology2020

Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.

Soudeh Ghafouri-Fard, Rezvan Noroozi, Mir Davood Omrani, Wojciech Branicki, Ewelina Pośpiech, Arezou Sayad, Krzysztof Pyrc, Paweł P Łabaj, Reza Vafaee, Mohammad Taheri and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in Vascular pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Life (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Potential Genes Associated with COVID-19 and Comorbidity.International journal of medical sciences · 2022
    Article
  13. Article
  14. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  15. An Organometallic Strategy for Cysteine Borylation.Journal of the American Chemical Society · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Soudeh Ghafouri-FardDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rezvan NorooziMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.
Mir Davood OmraniDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Wojciech BranickiMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.
Ewelina PośpiechMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.
Arezou SayadDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Krzysztof PyrcMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.
Paweł P ŁabajMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.
Reza VafaeeProteomics Research Center, Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad TaheriUrogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: mohammad_823@yahoo.com.
Marek SanakDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland. Electronic address: nfsanak@cyf-kr.edu.pl.
Jagiellonian University · PLShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiotensin-converting enzyme (ACE) and its homologue, ACE2, have been mostly associated with hypertensive disorder. However, recent pandemia of SARS-CoV-2 has put these proteins at the center of attention, as this virus has been shown to exploit ACE2 protein to enter cells. Clear difference in the response of affected patients to this virus has urged researchers to find the molecular basis and pathophysiology of the cell response to this virus. Different levels of expression and function of ACE proteins, underlying disorders, consumption of certain medications and the existence of certain genomic variants within ACE genes are possible explanations for the observed difference in the response of individuals to the SARS-CoV-2 infection. In the current review, we discuss the putative mechanisms for this observation.

Indexed as

Coronavirus InfectionsCOVID-19HumansPandemicsPeptidyl-Dipeptidase APneumonia, ViralACE protein, humanPeptidyl-Dipeptidase AACEAngiotensin-converting enzymeSARS-COV-2

Identifiers

PMID32423553
PMCPMC7211701
OpenAlexW3023496712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.